Dallas, TX 12/18/2008 1:31:29 AM
News / Finance

OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, December 17th DVAX, ANSV, GERS, CADX, ACTC

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.

Our Stocks to Watch today include Dynavax Technologies Corp. (Nasdaq: DVAX), Anesiva Inc. (Nasdaq: ANSV), GreenShift Corp. (OTCBB: GERS), Cadence Pharmaceuticals Inc. (Nasdaq: CADX) and Advanced Cell Technology Inc. (OTC: ACTC).

For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/microcap.htm

DYNAVAX TECHNOLOGIES INCORPORATED (NASDAQ: DVAX)

"Up 208.08% in morning trading"

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops a diversified, well-funded pipeline of novel Toll-like Receptor (TLR) product candidates. Based on Dynavax’s proprietary technology platform, these products specifically modify the innate immune response to infectious, respiratory, autoimmune, and inflammatory diseases. Dynavax’s product programs are supported by global partnerships with leading pharmaceutical companies such as Merck & Co., Inc., GlaxoSmithKline, and AstraZeneca AB, as well as funding from Symphony Dynamo, Inc. and the National Institutes of Health.

ANESIVA INCORPORATED (NASDAQ: ANSV)

"Up 112.28% in morning trading"

Anesiva, Inc. seeks to be a leader in the development of novel pharmaceutical products for pain management. The company's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. Adlea has been shown in previous clinical trials to provide extended pain relief after only a single administration in multiple indications for site-specific, acute and chronic, moderate-to-severe pain. Anesiva is based in South San Francisco, CA.

GREENSHIFT CORPORATION (OTCBB: GERS)

"Up 14.94% in morning trading"

GreenShift Corporation (OTCBB: GERS) develops and commercializes clean technologies that facilitate the efficient use of natural resources. GreenShift’s revenue model is based on the use of its proprietary technologies to become a leading producer of biomass-derived products, and to do so at reduced cost and risk by extracting and refining raw materials that other producers cannot access or process. GreenShift currently owns and operates six production facilities – four corn oil extraction facilities based on GreenShift’s patent-pending corn oil extraction technologies, one biodiesel production facility, and one vegetable oilseed crushing facility.

CADENCE PHARMACEUTICALS INCORPORATED (NASDAQ: CADX)

"Up 32.00% in morning trading"

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance™ (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard™ (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections.

ADVANCED CELL TECHNOLOGY INCORPORATED (OTC: ACTC)

"Up 17.39% in morning trading"

Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company also develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. It also plans to develop and commercialize products for use in the treatment of an array of chronic degenerative diseases and in regenerative repair of acute disease, such as trauma, infarction, and burns. The company has research and license agreements with University of Massachusetts, Wake Forest University, WiCell Research Institute, Inc., Kirin Beer Kabushiki Kaisha, and Start Licensing. Advanced Cell Technology, Inc. is headquartered in Worcester, Massachusetts.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has been two thousand dollars by a third party for a one-time ACTC email send.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.